CAS 1655504-04-3

Formula: C26H25N3O3

InChI: InChI=1S/C26H25N3O3/c1-2-24(30)29-16-14-18(15-17-29)23-13-12-22(26(27)31)25(28-23)19-8-10-21(11-9-19)32-20-6-4-3-5-7-20/h2-13,18H,1,14-17H2,(H2,27,31)

InChI key: MZPVEMOYADUARK-UHFFFAOYSA-N

SMILES: C=CC(=O)N1CCC(CC1)C2=NC(=C(C=C2)C(=O)N)C3=CC=C(C=C3)OC4=CC=CC=C4

6-(1-Acryloylpiperidin-4-Yl)-2-(4-Phenoxyphenyl)Nicotinamide

CAS: 1655504-04-3

6-(1-Acryloylpiperidin-4-Yl)-2-(4-Phenoxyphenyl)Nicotinamide

Formula: C₂₆H₂₅N₃O₃

Purity: 98%

Molecular weight: 427.5

Ref: 54-OR1023016

6-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide

CAS: 1655504-04-3

Formula: C₂₆H₂₅N₃O₃

Purity: 98%

Color and Shape: Solid

Molecular weight: 427.4950

Ref: IN-DA01KFHU

Orelabrutinib

CAS: 1655504-04-3

Orelabrutinib (ICP-022) is an orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK).

Formula: C₂₆H₂₅N₃O₃

Purity: 97.77% - 99.54%

Color and Shape: Solid

Molecular weight: 427.495

Ref: TM-T12317

Orelabrutinib

CAS: 1655504-04-3

Orelabrutinib

Formula: C₂₆H₂₅N₃O₃

Purity: ≥95%

Molecular weight: 427.49

Ref: 54-BUP12496

Orelabrutinib

CAS: 1655504-04-3

Orelabrutinib is a small-molecule Bruton’s tyrosine kinase (BTK) inhibitor, which is synthesized chemically. This selective inhibitor targets BTK, a key enzyme involved in the B-cell receptor signaling pathway. By binding covalently to cysteine-481 in BTK, orelabrutinib effectively blocks the downstream signaling, leading to apoptosis of malignant B-cells.

Formula: C₂₆H₂₅N₃O₃

Purity: Min. 95%

Molecular weight: 427.5 g/mol

Ref: 3D-FRC50404

Orelabrutinib

CAS: 1655504-04-3

Formula: C₂₆H₂₅N₃O₃

Molecular weight: 427.5

Ref: BE-MU-7996

Orelabrutinib

CAS: 1655504-04-3

6-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide

Formula: C₂₆H₂₅N₃O₃

Purity: 98%

Molecular weight: 427.5

Ref: IN-DG01296256

6-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide

CAS: 1655504-04-3

Purity: 98%

Molecular weight: 427.5039978

Ref: 10-F549430

Orelabrutinib (Standard)

CAS: 1655504-04-3

Orelabrutinib (Standard) is a reference standard for research and analysis in studies involving Orelabrutinib. Orelabrutinib (ICP-022) is an orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK).

Formula: C₂₆H₂₅N₃O₃

Color and Shape: Solid

Molecular weight: 427.49

Ref: TM-TMSM-3628